<b id="lnedg"><form id="lnedg"></form></b>
<cite id="lnedg"><noscript id="lnedg"><samp id="lnedg"></samp></noscript></cite><rt id="lnedg"><optgroup id="lnedg"><acronym id="lnedg"></acronym></optgroup></rt>
<b id="lnedg"></b>

    <font id="lnedg"></font>

    <rt id="lnedg"></rt>
  1. <tt id="lnedg"></tt>
    <rt id="lnedg"></rt>

    <tt id="lnedg"></tt><u id="lnedg"><tbody id="lnedg"><label id="lnedg"></label></tbody></u>

        <cite id="lnedg"></cite>
        1. Products

           Pravastatin Sodium
           Mycophenolic Acid

          Contact: Mr. Kang / Ms. Lin
          TEL:  0086-763-3865280
          FAX:  0086-763-3366526
          ADD:  Renmin One Road 
           Qingyuan Guangdong
          P.C.:  511515






          Common Name:Mycophenolic Acid

          Specifications:In-house specifications (Content: more than 95%)

          Registry Number:24280-93-1

          Molecular Formula:C17H20O6

          Molecular Mass:320.34

          Structural Formula

          Chemical  Name:6-(1, 3-Dihydro-7-hydroxy-5-methoxy-4-methyl-1-oxoisobenzofuran-6-yl)-4-methyl-4-hexanoic acid
          Appearance: Off-white to yellowish crystalline powder
          Therapeutic Category:Mycophenolic acid (MPA) is marketed as the prodrug mycophenolate mofetil (MMF).
          Mechanism of action: Mycophenolic Acid (MPA) is a potent, selective, noncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase(MPDH), the enzyme that controls the rate of synthesis of guanine monophosphate in the de novo pathway of purine synthesis used in the proliferation of B and T lymphocytes. Mycophenolate mofetil (MMF) is the 2-morpholinoethyl ester prodrug of MPA and is metabolized in the liver to the active moiety mycophenolic acid.
          Download the contract



          粵公網安備 44180202000306號  網站備案:粵ICP備16104045號 互聯網藥品信息服務資格證書(粵)—非經營性—2021—0443